openPR Logo
Press release

Global Non-Invasive Prenatal Testing (NIPT) Market By Top Players: Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics.

02-04-2021 12:52 PM CET | Health & Medicine

Press release from: Prophecy Market Insights

Prophecy Market Insights

Prophecy Market Insights

The report "Global Non-Invasive Prenatal Testing (NIPT) Market, By Product Type (Devices, Consumables, and Others), By Techniques (cfDNA, Biochemical Screening Tests, and Ultrasound Detection), By Application (Trisomy, Microdeletion syndrome, and Others), By End-User (Diagnostic Laboratories, Hospitals, and Cell DNA screening), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

In April 2017, Illumina, Inc. introduced VeriSeq NIPT solution in Europe (CE marked), which is useful for screening Trisomy (Down’s syndrome, Sex Chromosome Disorders, Microdeletion Syndrome).
In January 2017, Agilent Technology acquired Multiplicom N.V. (Belgium) in order to create comprehensive offerings for next-generation sequencing solutions.
In January 2019, Yourgene Health plc (U.K.) launched the Sage 32 plex test which uses Thermo Fisher’s Ion Torrent sequencing technology to detect placental cff-DNA in a maternal blood sample.

Sample Copy of Reports: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/4519
Analyst View:

High risk of chromosomal abnormalities with increasing maternal age

Maternal age plays an important role in the health of the child and delay in the maternal age can lead to various risk such as decreased fertility, high blood pressure, and an increase in the risk of miscarriage, stillbirths, and maternal death. Moreover, advancing maternal age can increase the risk of genetic disorders in babies as a result of the improper chromosomal division. The resulting abnormalities in babies may include microcephaly; short neck; upward slanted eyes; poor muscle tone; and heart, intestine, and breathing problems. In order to detect genetic abnormalities resulting from improper chromosomal division, there is a growing demand for early screening in expecting mothers. Therefore, Non-invasive prenatal testing being the safest one is boosting the market.

Key Market Insights from the report:

The global non-invasive prenatal testing (NIPT) market accounted for US$ 4.3 billion in 2020 and is estimated to be US$ 11.8 billion by 2029 and is anticipated to register a CAGR of 11.9%. The market report has been segmented on the basis of product type, technique, application, end-user and region.

Depending upon product type, consumables segment dominated the overall NIPT market. The growth of this segment is mainly because of the increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and improvement of approvals or licenses for assays.
In terms of technique, the cfDNA segment is expected to show the highest CAGR during the forecast period due to technological advancements and increasing company initiatives to develop new products.
By application, trisomy segment dominates the market due to the increasing maternal age and the rising incidence of chromosomal abnormalities.
Based on the end user, diagnostic laboratories are estimated to have the highest revenue share due to the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.
By region, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The reason being the developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in these regions.

Get In-depth @ https://www.prophecymarketinsights.com/market_insight/Global-Non-Invasive-Prenatal-Testing-(NIPT)-Market-4519

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period

Company Profiles
Sequenom
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategies
Roche (Ariosa Diagnostics)
Natera
LabCorp
BGI Genomics
Quest Diagnostics
Illumina, Inc.
Laboratory Corporation of America Holdings
Yourgene Health
Berry Genomics

Contact Us:

Sales

Prophecy Market Insights

Phone: +1 860 531 2701

Email: sales@prophecymarketinsights.com

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Non-Invasive Prenatal Testing (NIPT) Market By Top Players: Sequenom, Roche (Ariosa Diagnostics); Natera, LabCorp, BGI Genomics; Quest Diagnostics, Illumina, Laboratory Corporation of America Holdings, Yourgene Health, and Berry Genomics. here

News-ID: 2236373 • Views:

More Releases from Prophecy Market Insights

Europe Digital Agriculture/Farming Market Set for Robust Growth Through 2035: Key Trends and Insights
Europe Digital Agriculture/Farming Market Set for Robust Growth Through 2035: Ke …
Introduction: The Europe Digital Agriculture/Farming Market is witnessing a transformative shift as the adoption of precision farming technologies, IoT-enabled devices, AI-driven analytics, and sustainable agricultural solutions continues to rise. With increasing demand for higher crop yields, resource optimization, and reduced environmental impact, digital farming solutions are emerging as a critical driver of modern agriculture in Europe. FOR MORE INFO: https://www.prophecymarketinsights.com/market_insight/europe-digital-agriculture-farming-market-6023 Market Overview: According to recent market insights, Europe's digital agriculture/farming market is expected to grow
AI Governance Market: Driving Responsible AI Adoption for a Sustainable Future
AI Governance Market: Driving Responsible AI Adoption for a Sustainable Future
Introduction The global AI Governance Market is gaining significant traction as artificial intelligence (AI) continues to transform industries, businesses, and societies. With growing concerns around ethics, bias, transparency, and regulatory compliance, AI governance has emerged as a crucial framework to ensure responsible deployment of AI technologies. Governments, enterprises, and technology providers are increasingly adopting governance solutions to align AI development with accountability, fairness, and long-term sustainability. 📌 Access the full research report
Rising Solar District Heating Demand in Europe | Market Trends, Players & SWOT Analysis
Rising Solar District Heating Demand in Europe | Market Trends, Players & SWOT A …
Pune, 29 September - The Europe Solar District Heating Market is projected to expand from USD 7.1 billion in 2024 to USD 14.5 billion by 2035, registering a CAGR of 7.4% between 2025 and 2030. The region holds the distinction of being the largest market for solar district heating in 2024, driven by increasing government initiatives for renewable energy adoption, rising energy demand in urban centers, and growing environmental awareness. Read
Digital Farming in Asia Pacific: Industry Insights, Key Players & Strategic Analysis
Digital Farming in Asia Pacific: Industry Insights, Key Players & Strategic Anal …
Pune, 29 Sep - The Asia Pacific Digital Agriculture/Farming Market is on a robust growth trajectory, projected to surge from USD 6.7 billion in 2025 to USD 16.9 billion by 2035, expanding at a CAGR of 9.4% during 2025-2030. This rapid growth reflects the increasing adoption of smart farming technologies aimed at boosting agricultural productivity, resource efficiency, and sustainability across the region. Read Report Insights Here: https://www.prophecymarketinsights.com/market_insight/asia-pacific-digital-agriculture-farming-market-6022 What is Digital Agriculture/Farming? Digital Agriculture,

All 5 Releases


More Releases for NIPT

Noninvasive Prenatal Testing (NIPT) Market | Counsyl, Illuminansyl, Intergrated …
The global noninvasive prenatal testing (nipt) market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the noninvasive prenatal testing (nipt) market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants. From the perspective of market dynamics, this report explores the factors driving
Noninvasive Prenatal Testing (NIPT) Market global outlook and forecast 2021 -202 …
The Global Noninvasive Prenatal Testing (NIPT) Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Noninvasive Prenatal Testing (NIPT) makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The
Non Invasive Prenatal Testing (NIPT) Market Worth $13.1 Billion by 2027
Meticulous Research- leading global market research company published a research report titled "Non Invasive Prenatal Testing (NIPT) Market by Product & Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) - Global Forecast to 2027". According to this latest publication from Meticulous Research, the global non-invasive prenatal testing market is expected to grow at a CAGR of 17.1% from 2019
Non-Invasive Prenatal Testing Market has been analyzed from 2 viewpoints: NIPT T …
Worldwide Market Reports recently released “Global Non-Invasive Prenatal Testing Market Research Report 2017” that centers around the latest developing trends and technologies in the Non-Invasive Prenatal Testing Market having Five Years of forecast period from 2017 to 2022 and considering Market status study from 2017 to 2022. During the research, noteworthy data was collected in order to shape the research document and make it a valuable resource for managers, industry executives
Indian NIPT Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Indian NIPT Market Outlook 2022 to its growing collection of premium market research reports. NIPT helps obstetricians and pregnant women over different age-groups to better manage their pregnancy at a very early stage. Over the last few years, an increasing number of women in Tier-1 cities in India are giving preference to their career, and are opting for childbearing at a
06-01-2017 | Health & Medicine
SA-BRC
Non-Invasive Prenatal Testing (NIPT) Market Forecast 2017-2021
Non-invasive prenatal testing (NIPT) has received importance in the recent past due to increasing awareness about genetic disorders and availability of accurate noninvasive tests. NIPT testing is non-invasive has no risk of miscarriage as compared to other tests such as chorionic villus sampling (CVS) or amniocentesis. Down syndrome is one of most commonly diagnosed using NIPT. Some of the key genetic disorders diagnosed using NIPT include Edward's syndrome, Patau syndrome